Jamshid Gholizadeh Navashenaq (Jamshid G Navashenaq)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Expert opinion on therapeutic targets

Phytotherapy research : PTR

IUBMB life

Cell biochemistry and function

This page only lists publications with an associated author ORCID identifier.

Publications

Amir Mohammad Nezhad Salari, Zahra Rasoulizadeh, Arezoo Gowhari Shabgah, Roghayyeh Vakili-Ghartavol, Ghasem Sargazi, Jamshid Gholizadeh Navashenaq
Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders. Cell biochemistry and function 42 (2) (2024)
Amir Mohammad Nezhad Salari, Zahra Rasoulizadeh, Arezoo Gowhari Shabgah, Roghayyeh Vakili-Ghartavol, Ghasem Sargazi, Jamshid Gholizadeh Navashenaq
Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders. Cell biochemistry and function 42 (2) (2024)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert opinion on therapeutic targets (2023)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert opinion on therapeutic targets 26 (12) (2023)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The Prognostic and Therapeutic Potential of CTLA-4 in Hematological Malignancies. Expert opinion on therapeutic targets (2023)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert opinion on therapeutic targets 26 (12) (2023)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert opinion on therapeutic targets 26 (12) (2023)
Mohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert opinion on therapeutic targets 26 (12) (2023)
Arezoo Gowhari Shabgah, Zaid Mahdi Jaber Al-Obaidi, Heshu Sulaiman Rahman, Walid Kamal Abdelbasset, Wanich Suksatan, Dmitry O Bokov, Lakshmi Thangavelu, Abduladheem Turki Jalil, Farhad Jadidi-Niaragh, Hamed Mohammadi, Kazem Mashayekhi, Jamshid Gholizadeh Navashenaq
Does CCL19 act as a double-edged sword in cancer development? Clinical and experimental immunology 207 (2) (2022)
Arezoo Gowhari Shabgah, Farhad Jadidi-Niaragh, Farnoosh Ebrahimzadeh, Hamed Mohammadi, Elham Askari, Naseh Pahlavani, Mahsa Malekahmadi, Maryam Ebrahimi Nik, Jamshid Gholizadeh Navashenaq
A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation. Cell biology international 46 (10) (2022)
Ramin Hosseinzadeh, Fahimeh Feizisani, Navid Shomali, Walid Kamal Abdelbasset, Maryam Hemmatzadeh, Jamshid Gholizadeh Navashenaq, Farhad Jadidi-Niaragh, Dmitry O Bokov, Morteza Janebifam, Hamed Mohammadi
PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity. IUBMB life 73 (11) (2022)
Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, Atefeh Khodakarami, Hamed Mohammadi, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia. IUBMB life (2022)
Elyas Nattagh-Eshtivani, Alireza Gheflati, Hanieh Barghchi, Pegah Rahbarinejad, Kadda Hachem, Mohammed Nader Shalaby, Walid Kamal Abdelbasset, Golnaz Ranjbar, Dmitry Olegovich Bokov, Pegah Rahimi, Jamshid Gholizadeh Navashenaq, Naseh Pahlavani
The role of Pycnogenol in the control of inflammation and oxidative stress in chronic diseases: Molecular aspects. Phytotherapy research : PTR 36 (6) (2022)
Alireza Khiabani, Mohammad Hasan Kohansal, Aref Keshavarzi, Hojat Shahraki, Mohsen Kooshesh, Mohammadreza Karimzade, Jamshid Gholizadeh Navashenaq
CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review. Molecular genetics and genomics : MGG (2022)
Arezoo G Shabgah, Azwar Amir, Zhanna R Gardanova, Angelina Olegovna Zekiy, Lakshmi Thangavelu, Maryam Ebrahimi Nik, Majid Ahmadi, Jamshid Gholizadeh Navashenaq
Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches. Cancer medicine 10 (15) (2021)
Arezoo Gowhari Shabgah, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, Dmitry O Bokov, Wanich Suksatan, Lakshmi Thangavelu, Majid Ahmadi, Mahsa Malekahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq
A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections. Immunology (2021)
Arezoo Gowhari Shabgah, Fatemeh Norouzi, Mahdiyeh Hedayati-Moghadam, Davood Soleimani, Naseh Pahlavani, Jamshid Gholizadeh Navashenaq
A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. Nutrition & metabolism 18 (1) (2021)
Arezoo Gowhari Shabgah, Maytham T Qasim, Seyed Mojtaba Mostafavi, Angelina Olegovna Zekiy, Fatemeh Ezzatifar, Majid Ahmadi, Saeed Mohammadian Haftcheshmeh, Jamshid Gholizadeh Navashenaq
CXC chemokine ligand 16: a Swiss army knife chemokine in cancer. Expert reviews in molecular medicine 23 (2021)
Arezoo G Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq
Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB life 73 (4) (2021)
Davood Soleimani, Mitra Rezaie Gorgani, Farnood Rajabzadeh, Jamshid Gholizadeh Navashenaq, Mohammadreza Abbaspour, Mahsa Miryan, Farkhondeh Razmpour, Golnaz Ranjbar, Reza Rezvani, Lida Jarahi, Seyed Isaac Hashemy, Ladan Goshayeshi, Mohsen Nematy
Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial. Phytotherapy research : PTR 35 (3) (2020)
Davood Soleimani, Mahsa Miryan, Helda Tutunchi, Jamshid Gholizadeh Navashenaq, Ehsan Sadeghi, Majid Ghayour Mobarhan, Gordon A Ferns, Ostadrahimi Alireza
A systematic review of preclinical studies on the efficacy of propolis for the treatment of inflammatory bowel disease. Phytotherapy research : PTR 35 (2) (2020)
Safa Tahmasebi, Mohamed A El-Esawi, Zaid Hameed Mahmoud, Anton Timoshin, Hamed Valizadeh, Leila Roshangar, Mojtaba Varshoch, Aydin Vaez, Saeed Aslani, Jamshid Gholizadeh Navashenaq, Leili Aghebati-Maleki, Majid Ahmadi
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. Journal of cellular physiology 236 (7) (2020)

Jamshid Gholizadeh Navashenaq.css-eqlu8i{font-size:small;padding-left:4px;} (Jamshid G Navashenaq)

Publication Activity (10 Years)

Top Topics

Top Venues

Jamshid Gholizadeh Navashenaq (Jamshid G Navashenaq)